Safety and efficacy results of a phase II randomized, placebo-controlled, dose-ranging study of elnd005 (scyllo-inositol) in mild-to-moderate Alzheimer's diseaseStephen Salloway,Anton Porsteinsson,Reisa Sperling,Ron Keren,Christopher van Dyck,Pierre Tariot, Sid Gilman,Gerald Crans,Ramon Hernandez,Grainne Quinn, Menghis Bairu,Jesse Cedarbaum,Aleksandra Pastrak,Susan AbushakraAlzheimers & Dementia（2011）引用 1|浏览19暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
